Corcept (CORT) director-linked trust gifts 2,000 company shares

Rhea-AI Filing Summary

Corcept Therapeutics director James N. Wilson, through an entity associated with him, reported a bona fide gift of 2,000 shares of Corcept common stock on April 22, 2026. The gift was made by the James N. Wilson and Pamela D. Wilson Trust and is classified under transaction code G, indicating a non-market transfer with no sale proceeds.

After the gift, that trust still held 1,095,532 shares of Corcept common stock indirectly. The filing also lists additional indirect holdings, including 200,000 shares in the Pamela D. Wilson 2025 Grantor Retained Annuity Trust, 200,000 shares in the James N. Wilson 2025 Grantor Retained Annuity Trust, and 901,067 shares held by James and Pamela Wilson Family Partners. A footnote states that Wilson has voting power over certain entities’ shares under voting agreements and disclaims beneficial ownership except to the extent of his pecuniary interest.

Insider Trade Summary

2,000 shares gifted

Mixed 4 txns

Insider WILSON JAMES N

Role null

Type	Security	Shares	Price	Value
Gift	Common Stock	2,000	$0.00	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 1,095,532 shares (Indirect, James N. Wilson and Pamela D. Wilson Trust)

Footnotes (1)

1. [object Object]

Key Figures

Gifted shares: 2,000 shares Trust holdings after gift: 1,095,532 shares Pamela D. Wilson 2025 GRAT holdings: 200,000 shares +3 more

6 metrics

Gifted shares 2,000 shares Bona fide gift of common stock on April 22, 2026

Trust holdings after gift 1,095,532 shares James N. Wilson and Pamela D. Wilson Trust post-transaction balance

Pamela D. Wilson 2025 GRAT holdings 200,000 shares Indirect Corcept common stock holding entry

James N. Wilson 2025 GRAT holdings 200,000 shares Indirect Corcept common stock holding entry

Family Partners holdings 901,067 shares James and Pamela Wilson Family Partners indirect holding entry

Gift price per share $0.00 per share Reported price for the 2,000-share bona fide gift

Key Terms

Grantor Retained Annuity Trust, bona fide gift, voting agreements, pecuniary interest

4 terms

Grantor Retained Annuity Trust financial

"Pamela D. Wilson 2025 Grantor Retained Annuity Trust."

A grantor retained annuity trust (GRAT) is an estate-planning tool where the person who creates the trust transfers assets into it but receives fixed cash payments (an annuity) from the trust for a set number of years; whatever remains after that term passes to designated beneficiaries. It matters to investors because it can shift future appreciation of assets out of the creator’s taxable estate—like putting an asset into a timed vending machine that pays you fixed amounts while any extra value that grows inside the machine goes to heirs with reduced gift or estate tax consequences.

bona fide gift financial

"transaction_code_description": "Bona fide gift""

voting agreements financial

"has voting power over the shares held ... pursuant to voting agreements"

A voting agreement is a legally binding deal where shareholders promise to cast their votes the same way on corporate matters, such as choosing directors or approving big transactions. Think of it like a neighborhood group agreeing to support the same candidate so they can decide how the block is run; for investors, these pacts can change who controls a company, influence strategy and risk, and affect the value and liquidity of shares.

pecuniary interest financial

"disclaims beneficial ownership ... except to the extent of his pecuniary interest therein"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WILSON JAMES N

(Last) (First) (Middle)

C/O CORCEPT THERAPEUTICS INCORPORATED

101 REDWOOD SHORES PARKWAY

(Street)

REDWOOD CITY CALIFORNIA 94065

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CORCEPT THERAPEUTICS INC [ CORT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/22/2026		G		2,000	D	$0.00	1,095,532	I	James N. Wilson and Pamela D. Wilson Trust(1)
Common Stock								901,067	I	James and Pamela Wilson Family Partners(1)
Common Stock								200,000	I	James N. Wilson 2025 Grantor Retained Annuity Trust.
Common Stock								200,000	I	Pamela D. Wilson 2025 Grantor Retained Annuity Trust.

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.

	/s/ Joseph Douglas Lyon, as attorney-in-fact for James N. Wilson	04/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did James N. Wilson report in his latest Form 4 for CORCEPT (CORT)?

James N. Wilson reported a bona fide gift of 2,000 shares of Corcept common stock by the James N. Wilson and Pamela D. Wilson Trust. The transaction occurred on April 22, 2026 and is coded G, indicating a non-market gift disposition rather than an open-market sale.

Was the CORCEPT (CORT) Form 4 transaction a sale or a gift?

The transaction was a gift, not a sale. The filing shows a bona fide gift of 2,000 Corcept common shares by an indirectly owned trust, with a reported price of $0.00 per share, which is consistent with a non-cash, non-market transfer classified under transaction code G.

How many CORCEPT (CORT) shares did the Wilson trust hold after the reported gift?

Following the 2,000-share gift, the James N. Wilson and Pamela D. Wilson Trust held 1,095,532 Corcept common shares indirectly. This post-transaction balance is explicitly listed in the filing as the total shares following the transaction for that trust’s indirect ownership line.

What other indirect CORCEPT (CORT) holdings related to James N. Wilson are disclosed?

The filing lists 200,000 shares in the Pamela D. Wilson 2025 Grantor Retained Annuity Trust, 200,000 shares in the James N. Wilson 2025 Grantor Retained Annuity Trust, and 901,067 shares held by James and Pamela Wilson Family Partners, all reported as indirect holdings of Corcept common stock.

Does James N. Wilson claim full beneficial ownership of the reported CORCEPT (CORT) shares?

No. A footnote explains that he has voting power over shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners under voting agreements, but he disclaims beneficial ownership of those shares except to the extent of his pecuniary interest in the entities.